Freestone Grove Partners LP Invests $7.78 Million in Trupanion, Inc. (NASDAQ:TRUP)

Freestone Grove Partners LP bought a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 161,327 shares of the financial services provider's stock, valued at approximately $7,776,000. Freestone Grove Partners LP owned 0.38% of Trupanion at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TRUP. Amundi increased its holdings in shares of Trupanion by 193.2% in the fourth quarter. Amundi now owns 16,828 shares of the financial services provider's stock valued at $784,000 after purchasing an additional 11,088 shares during the last quarter. Barclays PLC increased its position in shares of Trupanion by 259.2% during the third quarter. Barclays PLC now owns 65,498 shares of the financial services provider's stock valued at $2,750,000 after acquiring an additional 47,262 shares during the last quarter. Vanguard Group Inc. raised its position in Trupanion by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after purchasing an additional 45,653 shares during the period. Wealthfront Advisers LLC acquired a new position in Trupanion during the 4th quarter worth about $845,000. Finally, Illinois Municipal Retirement Fund purchased a new position in shares of Trupanion in the fourth quarter valued at approximately $834,000.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the company's stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $33.34, for a total value of $133,360.00. Following the transaction, the chief executive officer now directly owns 118,784 shares in the company, valued at approximately $3,960,258.56. This represents a 3.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Brenna Mcgibney sold 5,000 shares of Trupanion stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $32.99, for a total transaction of $164,950.00. Following the sale, the insider now owns 3,738 shares of the company's stock, valued at approximately $123,316.62. This trade represents a 57.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 33,792 shares of company stock valued at $1,122,802. 5.50% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Stifel Nicolaus cut their target price on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Lake Street Capital lowered their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research report on Friday. Finally, Piper Sandler dropped their price target on Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Trupanion presently has a consensus rating of "Moderate Buy" and an average target price of $51.80.

Trupanion Price Performance

Trupanion stock traded down $0.08 during midday trading on Tuesday, reaching $44.73. The company's stock had a trading volume of 571,730 shares, compared to its average volume of 654,804. The stock's 50 day simple moving average is $35.82 and its 200 day simple moving average is $44.73. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71. The firm has a market capitalization of $1.90 billion, a PE ratio of -194.48, a P/E/G ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a fifty-two week low of $20.05 and a fifty-two week high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, topping analysts' consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The company had revenue of $341.98 million for the quarter, compared to the consensus estimate of $337.81 million. During the same period in the previous year, the business earned ($0.16) earnings per share. Trupanion's quarterly revenue was up 11.7% compared to the same quarter last year. On average, equities research analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.